mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.07 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.07 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.07 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.07 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.08 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.08 |